Prelude Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Prelude Capital Management’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$31.9K	Buy
2018 Q3	–	Sell
2018 Q2	$10K	Buy
2017 Q2	–	Sell
2017 Q1	$308K	Buy
2016 Q4	$134K	Buy